Guerbet is a human-scale company that aims to become a new global leader in medical imaging. Pioneer in contrast media with 90 years' experience, Guerbet is the only pharmaceutical group dedicated to medical imaging worldwide, with a presence in almost 80 countries via a network of subsidiaries and distributors. The company offers a comprehensive range of CT scan, Cath Lab, Magnetic Resonance Imaging (MRI) and Interventional Radiology and Theranostics (IRT) products, along with a range of injectors and related medical devices to improve patients' diagnosis, prognosis and quality of life. Advancing in innovation solutions, the diagnosis of major diseases (cardiovascular diseases, cancers, diseases of the central nervous system) and interventional radiology while reconciling efficacy and cost containment, are at the heart of Guerbet's mission.

Type
Public
HQ
Villepinte, FR
Founded
1926
Size (employees)
2,521 (est)
Guerbet was founded in 1926 and is headquartered in Villepinte, FR

Guerbet Office Locations

Guerbet has an office in Villepinte

Guerbet Data and Metrics

Guerbet Financial Metrics

Guerbet's revenue was reported to be €490.3 m in FY, 2015 which is a 20% increase from the previous period.
Numbers are in €, EUR

Revenue (FY, 2015)

490.3 m

Revenue growth (FY, 2014 - FY, 2015), %

20%

Gross profit (FY, 2015)

386.8 m

Gross profit margin (FY, 2015), %

79%

Net income (FY, 2015)

39.9 m

EBIT (FY, 2015)

56.1 m

EBITDA (FY, 2015)

84.4 m

Market capitalization (12-May-2017)

1 b

Closing share price (12-May-2017)

81.7

Cash (31-Dec-2015)

54.4 m

EV

1.3 b
Guerbet's current market capitalization is €1 b.
Numbers are in €, EURFY, 2014FY, 2015

Revenue

409.7 m490.3 m

Revenue growth, %

20%

Cost of goods sold

90.4 m103.5 m

Gross profit

319.3 m386.8 m

Gross profit Margin, %

78%79%

Sales and marketing expense

113.3 m125.6 m

General and administrative expense

123.4 m155.9 m

Operating expense total

255.7 m304 m

Depreciation and amortization

24.8 m26.8 m

EBITDA

67.7 m84.4 m

EBITDA margin, %

17%17%

EBIT

38.8 m56.1 m

EBIT margin, %

9%11%

Interest expense

1.9 m1.2 m

Income tax expense

10.1 m18.4 m

Net Income

26.1 m39.9 m
Numbers are in €, EURY, 2014Y, 2015

Cash

20.4 m54.4 m

Total Assets

475.6 m898.8 m

Total Debt

81.2 m342.2 m

Total Liabilities

216.5 m615 m
Numbers are in €, EURFY, 2014FY, 2015

Cash From Operating Activities

60 m74.3 m
Y, 2015

EV/EBITDA

15.5 x

EV/EBIT

23.3 x

EV/CFO

17.6 x

Guerbet Market Value History

Guerbet Revenue Breakdown

Guerbet Online and Social Media Presence

Guerbet Company Life and Culture

You may also be interested in